François Malouin
Fondateur chez Ulysses Pharmaceuticals Products, Inc.
Provenance du réseau au premier degré de François Malouin
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Ulysses Pharmaceuticals Products, Inc.
 Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Ulysses Pharmaceuticals discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections. The company was founded in December 2001 by Suzanne Chamberland, Roger Léger, and François Malouin and is headquartered in Sherbrooke, Canada
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à François Malouin via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Chief Executive Officer | |
| Lederle International | Corporate Officer/Principal | ||
Ulysses Pharmaceuticals Pvt Ltd.
 Ulysses Pharmaceuticals Pvt Ltd. Pharmaceuticals: OtherHealth Technology Ulysses Pharmaceuticals Pvt Ltd. provides homeopathic modern medicines. It engages in the discovery and development of novel and safe antimicrobial agents for the treatment of severe and recurrent infections occurring in human. The company was founded in July 2001 and is headquartered in Kolkata, India. | Pharmaceuticals: Other | Founder | |
| University of Kent | College/University | Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
Gladius Pharmaceuticals Corp.
 Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Biotechnology | Chief Executive Officer | |
| CHITOGENX INC. | Biotechnology | Chairman | |
| Syzent Partners Ltd. | Founder | ||
| Sopharmia, Inc. | Chairman | ||
| Affinite Instruments | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 6 |
| Canada | 6 |
| Inde | 2 |
| Royaume-Uni | 2 |
| Turquie | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 3 |
Opérationnelle
| President | 5 |
| Chief Executive Officer | 3 |
| Director/Board Member | 3 |
| Chairman | 3 |
| Corporate Officer/Principal | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Atkin | 13 |
| Suzanne Chamberland | 2 |
- Bourse
- Insiders
- François Malouin
- Connexions Sociétés
